Alimera Sciences, Inc. (ALIM)
NASDAQ: ALIM · Real-Time Price · USD
5.55
-0.01 (-0.09%)
Sep 13, 2024, 11:46 AM EDT - Market open
Alimera Sciences Market Cap
Alimera Sciences has a market cap or net worth of $301.56 million as of September 13, 2024. Its market cap has increased by 925.71% in one year.
Market Cap
301.56M
Enterprise Value
363.45M
1-Year Change
925.71%
Ranking
Category
Stock Price
$5.55
Market Cap Chart
Since April 22, 2010, Alimera Sciences's market cap has decreased from $341.60M to $301.56M, a decrease of -11.72%. That is a compound annual growth rate of -0.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2024 | 300.70M | 32.82% |
| Dec 29, 2023 | 226.40M | 1,091.58% |
| Dec 30, 2022 | 19.00M | -46.63% |
| Dec 31, 2021 | 35.60M | 64.06% |
| Dec 31, 2020 | 21.70M | -42.29% |
| Dec 31, 2019 | 37.60M | -25.25% |
| Dec 31, 2018 | 50.30M | -45.33% |
| Dec 29, 2017 | 92.00M | 31.24% |
| Dec 30, 2016 | 70.10M | -34.97% |
| Dec 31, 2015 | 107.80M | -56.07% |
| Dec 31, 2014 | 245.40M | 65.14% |
| Dec 31, 2013 | 148.60M | 200.20% |
| Dec 31, 2012 | 49.50M | 25.95% |
| Dec 30, 2011 | 39.30M | -87.86% |
| Dec 31, 2010 | 323.70M | -5.24% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Poseida Therapeutics | 289.42M |
| PepGen | 289.40M |
| enGene Holdings | 285.76M |
| Viemed Healthcare | 283.82M |
| Precigen | 281.60M |
| Adaptimmune Therapeutics | 280.04M |
| Corvus Pharmaceuticals | 279.92M |
| Heron Therapeutics | 279.83M |